Cargando…
Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study
BACKGROUND: The World Health Organization currently recommends combined streptomycin and rifampicin antibiotic treatment as first-line therapy for Mycobacterium ulcerans infections. Alternatives are needed when these are not tolerated or accepted by patients, contraindicated, or neither accessible n...
Autores principales: | O'Brien, Daniel P., McDonald, Anthony, Callan, Peter, Robson, Mike, Friedman, N. Deborah, Hughes, Andrew, Holten, Ian, Walton, Aaron, Athan, Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260310/ https://www.ncbi.nlm.nih.gov/pubmed/22272368 http://dx.doi.org/10.1371/journal.pntd.0001473 |
Ejemplares similares
-
Incidence, clinical spectrum, diagnostic features, treatment and predictors of paradoxical reactions during antibiotic treatment of Mycobacterium ulcerans infections
por: O’Brien, Daniel P, et al.
Publicado: (2013) -
Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease
por: O’Brien, Daniel P., et al.
Publicado: (2018) -
Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal Outcomes
por: O’Brien, Daniel P., et al.
Publicado: (2015) -
Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia
por: Tai, Alex Y.C., et al.
Publicado: (2018) -
Clinical Features and Risk Factors of Oedematous Mycobacterium ulcerans Lesions in an Australian Population: Beware Cellulitis in an Endemic Area
por: O'Brien, Daniel P., et al.
Publicado: (2014)